X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
- chromosome 19 -
| Symbol | GoldenPath (Mb) | Location | Description |
|---|---|---|---|
| SHC2 | 367.583 | 19p13.3 | SHC (Src homology 2 domain containing) transforming protein 2 |
| CDC34 | 482.733 | 19p13.3 | cell division cycle 34 homolog (S. cerevisiae) |
| GZMM | 495.027 | 19p13.3 | granzyme M (lymphocyte met-ase 1) |
| BSG | 523.537 | 19p13.3 | basigin (Ok blood group) |
| FGF22 | 590.926 | 19p13.3 | fibroblast growth factor 22 |
| RNF126 | 598.530 | 19p13.3 | ring finger protein 126 |
| FSTL3 | 627.389 | 19p13 | follistatin-like 3 (secreted glycoprotein) |
| PTBP1 | 748.411 | 19p13.3 | polypyrimidine tract binding protein 1 |
| PRG2 | 763.518 | 19p13.3 | plasticity-related gene 2 |
| AZU1 | 778.831 | 19p13.3 | azurocidin 1 (cationic antimicrobial protein 37) |
| PRTN3 | 791.985 | 19p13.3 | proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen) |
| ELA2 | 803.291 | 19p13.3 | elastase 2, neutrophil |
| KISS1R | 868.358 | 19p13.3 | KISS1 receptor |
| ARID3A | 877.037 | 19p13.3 | AT rich interactive domain 3A (BRIGHT-like) |
| C19orf6 | 960.650 | 19p13.3 | chromosome 19 open reading frame 6 |
| GPX4 | 1055.649 | 19p13.3 | glutathione peroxidase 4 (phospholipid hydroperoxidase) |
| STK11 | 1156.798 | 19p13.3 | serine/threonine kinase 11 |
| CIRBP | 1220.347 | 19p13.3 | cold inducible RNA binding protein |
| EFNA2 | 1237.168 | 19p13 | ephrin-A2 |
| MUM1 | 1306.010 | 19p13.3 | melanoma associated antigen (mutated) 1 |
| RPS15 | 1389.363 | 19p13.3 | ribosomal protein S15 |
| APC2 | 1401.148 | 19p13.3 | adenomatosis polyposis coli 2 |
| MEX3D | 1505.668 | 19p13.3 | mex-3 homolog D (C. elegans) |
| MBD3 | 1527.678 | 19p13.3 | methyl-CpG binding domain protein 3 |
| TCF3 | 1560.295 | 19p13.3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) |
| CSNK1G2 | 1892.161 | 19p13.3 | casein kinase 1, gamma 2 |
| MKNK2 | 1988.470 | 19p13.3 | MAP kinase interacting serine/threonine kinase 2 |
| AP3D1 | 2051.994 | 19p13.3 | adaptor-related protein complex 3, delta 1 subunit |
| DOT1L | 2115.148 | 19p13.3 | DOT1-like, histone H3 methyltransferase (S. cerevisiae) |
| AMH | 2200.113 | 19p13.3 | anti-Mullerian hormone |
| OAZ1 | 2220.520 | 19p13.3 | ornithine decarboxylase antizyme 1 |
| SPPL2B | 2279.629 | 19p13.3 | signal peptide peptidase-like 2B |
| TIMM13 | 2376.622 | 19p13.3 | translocase of inner mitochondrial membrane 13 homolog (yeast) |
| GADD45B | 2427.135 | 19p13.3 | growth arrest and DNA-damage-inducible, beta |
| GNG7 | 2462.218 | 19p13.3 | guanine nucleotide binding protein (G protein), gamma 7 |
| DIRAS1 | 2665.565 | 19p13.3 | DIRAS family, GTP-binding RAS-like 1 |
| SGTA | 2705.712 | 19p13 | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
| AES | 3003.908 | 19p13.3 | amino-terminal enhancer of split |
| GNA11 | 3045.408 | 19p13.3 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
| GNA15 | 3087.191 | 19p13.3 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
| FZR1 | 3473.954 | 19p13.3 | fizzy/cell division cycle 20 related 1 (Drosophila) |
| HMG20B | 3523.943 | 19p13.3 | high-mobility group 20B |
| TBXA2R | 3545.504 | 19p13.3 | thromboxane A2 receptor |
| PIP5K1C | 3581.182 | 19p13.3 | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
| MATK | 3728.968 | 19p13.3 | megakaryocyte-associated tyrosine kinase |
| ITGB1BP3 | 3884.101 | 19p13.3 | integrin beta 1 binding protein 3 |
| DAPK3 | 3909.452 | 19p13.3 | death-associated protein kinase 3 |
| EEF2 | 3927.055 | 19pter-q12 | eukaryotic translation elongation factor 2 |
| PIAS4 | 3958.749 | 19p13.3 | protein inhibitor of activated STAT, 4 |
| ZBTB7A | 3996.218 | 19p13.3 | zinc finger and BTB domain containing 7A |
| MAP2K2 | 4041.329 | 19p13.3 | mitogen-activated protein kinase kinase 2 |
| SIRT6 | 4125.107 | 19p13.3 | sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae) |
| SHD | 4230.659 | 19p13.3 | Src homology 2 domain containing transforming protein D |
| FSD1 | 4255.691 | 19p13.3 | fibronectin type III and SPRY domain containing 1 |
| SH3GL1 | 4311.368 | 19p13.3 | SH3-domain GRB2-like 1 |
| CHAF1A | 4353.660 | 19p13.3 | chromatin assembly factor 1, subunit A (p150) |
| TNFAIP8L1 | 4590.530 | 19p13.3 | tumor necrosis factor, alpha-induced protein 8-like 1 |
| DPP9 | 4626.237 | 19p13.3 | dipeptidyl-peptidase 9 |
| FEM1A | 4742.728 | 19p13.3 | fem-1 homolog a (C. elegans) |
| M6PRBP1 | 4789.346 | 19p13.3 | mannose-6-phosphate receptor binding protein 1 |
| UHRF1 | 4861.566 | 19p13.3 | ubiquitin-like, containing PHD and RING finger domains, 1 |
| JMJD2B | 4920.132 | 19p13.3 | jumonji domain containing 2B |
| PTPRS | 5156.520 | 19p13.3 | protein tyrosine phosphatase, receptor type, S |
| SAFB2 | 5538.011 | 19p13.3 | scaffold attachment factor B2 |
| SAFB | 5574.164 | 19p13.3-p13.2 | scaffold attachment factor B |
| NRTN | 5774.818 | 19p13.3 | neurturin |
| FUT6 | 5781.637 | 19p13.3 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) |
| FUT3 | 5793.899 | 19p13.3 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) |
| FUT5 | 5816.838 | 19p13.3 | fucosyltransferase 5 (alpha (1,3) fucosyltransferase) |
| RANBP3 | 5868.282 | 19p13.3 | RAN binding protein 3 |
| MLLT1 | 6161.393 | 19p13.3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 |
| CLPP | 6312.463 | 19p13.3 | ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli) |
| ALKBH7 | 6323.444 | 19p13.3 | alkB, alkylation repair homolog 7 (E. coli) |
| GTF2F1 | 6330.580 | 19p13.3 | general transcription factor IIF, polypeptide 1, 74kDa |
| KHSRP | 6364.119 | 19p13.3 | KH-type splicing regulatory protein |
| TNFSF9 | 6482.037 | 19p13.3 | tumor necrosis factor (ligand) superfamily, member 9 |
| CD70 | 6536.851 | 19p13 | CD70 molecule |
| TNFSF14 | 6615.566 | 19p13.3 | tumor necrosis factor (ligand) superfamily, member 14 |
| C3 | 6628.847 | 19p13.3-p13.2 | complement component 3 |
| TRIP10 | 6690.707 | 19p13.3 | thyroid hormone receptor interactor 10 |
| SH2D3A | 6703.175 | 19p13.3 | SH2 domain containing 3A |
| VAV1 | 6723.722 | 19p13.2 | vav 1 guanine nucleotide exchange factor |
| MBD3L2 | 7000.351 | 19p13.3 | methyl-CpG binding domain protein 3-like 2 |
| INSR | 7063.266 | 19p13.3-p13.2 | insulin receptor |
| ARHGEF18 | 7351.866 | 19p13.3 | rho/rac guanine nucleotide exchange factor (GEF) 18 |
| XAB2 | 7590.412 | 19p13.3 | XPA binding protein 2 |
| RETN | 7639.972 | 19p13.2 | resistin |
| FCER2 | 7659.663 | 19p13.3 | Fc fragment of IgE, low affinity II, receptor for (CD23) |
| CD209 | 7710.883 | 19p13 | CD209 molecule |
| MAP2K7 | 7874.765 | 19p13.3-p13.2 | mitogen-activated protein kinase kinase 7 |
| TIMM44 | 7897.604 | 19p13.3-p13.2 | translocase of inner mitochondrial membrane 44 homolog (yeast) |
| ELAVL1 | 7929.458 | 19p13.2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
| CCL25 | 8023.934 | 19p13.2 | chemokine (C-C motif) ligand 25 |
| ANGPTL4 | 8335.011 | 19p13.3 | angiopoietin-like 4 |
| RAB11B | 8361.296 | 19p13.2 | RAB11B, member RAS oncogene family |
| PRAM1 | 8460.941 | 19p13.2 | PML-RARA regulated adaptor molecule 1 |
| MYO1F | 8491.999 | 19p13.3-p13.2 | myosin IF |
| ADAMTS10 | 8551.126 | 19p13.3 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
| MBD3L1 | 8814.332 | 19p13.2 | methyl-CpG binding domain protein 3-like 1 |
| MUC16 | 8820.521 | 19p13.2 | mucin 16, cell surface associated |
| FBXL12 | 9781.945 | 19p13.2 | F-box and leucine-rich repeat protein 12 |
| PIN1 | 9806.999 | 19p13 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
| ANGPTL6 | 10064.013 | 19p13.2 | angiopoietin-like 6 |
| PPAN | 10077.965 | 19p13.2 | peter pan homolog (Drosophila) |
| DNMT1 | 10105.023 | 19p13.2 | DNA (cytosine-5-)-methyltransferase 1 |
| ICAM1 | 10242.517 | 19p13.3-p13.2 | intercellular adhesion molecule 1 (CD54), human rhinovirus receptor |
| ICAM4 | 10258.650 | 19p13.2-cen | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
| ICAM5 | 10261.655 | 19p13.2 | intercellular adhesion molecule 5, telencephalin |
| ICAM3 | 10305.452 | 19p13.3-p13.2 | intercellular adhesion molecule 3 |
| TYK2 | 10322.209 | 19p13.2 | tyrosine kinase 2 |
| CDC37 | 10362.809 | 19p13.2 | cell division cycle 37 homolog (S. cerevisiae) |
| PDE4A | 10402.521 | 19p13.2 | phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila) |
| KEAP1 | 10457.796 | 19p13.2 | kelch-like ECH-associated protein 1 |
| EDG8 | 10484.623 | 19p13.2 | sphingosine-1-phosphate receptor 5 |
| S1PR5 | 10484.623 | 19p13.2 | sphingosine-1-phosphate receptor 5 |
| ATG4D | 10515.647 | 19p13.2 | ATG4 autophagy related 4 homolog D (S. cerevisiae) |
| CDKN2D | 10538.139 | 19p13 | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| AP1M2 | 10544.348 | 19p13.2 | adaptor-related protein complex 1, mu 2 subunit |
| CARM1 | 10843.253 | 19p13.2 | coactivator-associated arginine methyltransferase 1 |
| LDLR | 11061.132 | 19p13.3 | low density lipoprotein receptor (familial hypercholesterolemia) |
| LOC55908 | 11209.817 | 19p13.2 | hepatocellular carcinoma-associated gene TD26 |
| RAB3D | 11296.094 | 19p13.2 | RAB3D, member RAS oncogene family |
| EPOR | 11349.475 | 19p13.3-p13.2 | erythropoietin receptor |
| RGL3 | 11366.001 | 19p13.2 | ral guanine nucleotide dissociation stimulator-like 3 |
| PRKCSH | 11407.269 | 19 | protein kinase C substrate 80K-H |
| CNN1 | 11510.579 | 19p13.2-p13.1 | calponin 1, basic, smooth muscle |
| ACP5 | 11546.475 | 19p13.3-p13.2 | acid phosphatase 5, tartrate resistant |
| MORG1 | 12641.517 | 19p13.13 | mitogen-activated protein kinase organizer 1 |
| JUNB | 12763.310 | 19p13.13 | jun B proto-oncogene |
| PRDX2 | 12772.427 | 19p13.2 | peroxiredoxin 2 |
| MAST1 | 12810.348 | 19p13.2 | microtubule associated serine/threonine kinase 1 |
| FARSA | 12894.284 | 19p13.2 | phenylalanyl-tRNA synthetase, alpha subunit |
| CALR | 12910.423 | 19p13.3-p13.2 | calreticulin |
| RAD23A | 12917.654 | 19p13.2 | RAD23 homolog A (S. cerevisiae) |
| GADD45GIP1 | 12925.973 | 19p13.2 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 |
| LYL1 | 13070.848 | 19p13.2 | lymphoblastic leukemia derived sequence 1 |
| BTBD14B | 13090.109 | 19p13.13 | BTB (POZ) domain containing 14B |
| IER2 | 13122.282 | 19p13.13 | immediate early response 2 |
| C19orf53 | 13746.257 | 19p13.13 | chromosome 19 open reading frame 53 |
| RFX1 | 13933.353 | 19p13.1 | regulatory factor X, 1 (influences HLA class II expression) |
| IL27RA | 14003.262 | 19p13.11 | interleukin 27 receptor, alpha |
| PRKACA | 14063.509 | 19p13.1 | protein kinase, cAMP-dependent, catalytic, alpha |
| ASF1B | 14091.322 | 19p13.12 | ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
| CD97 | 14353.213 | 19p13 | CD97 molecule |
| DDX39 | 14380.631 | 19p13.13 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 |
| PKN1 | 14412.086 | 19p13.12 | protein kinase N1 |
| PTGER1 | 14444.279 | 19p13.1 | prostaglandin E receptor 1 (subtype EP1), 42kDa |
| GIPC1 | 14449.572 | 19p13.1 | GIPC PDZ domain containing family, member 1 |
| DNAJB1 | 14486.582 | 19p13.2 | DnaJ (Hsp40) homolog, subfamily B, member 1 |
| CASP14 | 15024.015 | 19p13.1 | caspase 14, apoptosis-related cysteine peptidase |
| NOTCH3 | 15131.444 | 19p13.2-p13.1 | Notch homolog 3 (Drosophila) |
| ABHD9 | 15198.731 | 19p13.13 | abhydrolase domain containing 9 |
| BRD4 | 15209.302 | 19p13.1 | bromodomain containing 4 |
| AKAP8 | 15325.341 | 19p13.1 | A kinase (PRKA) anchor protein 8 |
| UCA1 | 15801.171 | 19p13 | urothelial cancer associated 1 |
| TPM4 | 16048.325 | 19p13.1 | tropomyosin 4 |
| RAB8A | 16083.490 | 19p13.2-p13.1 | RAB8A, member RAS oncogene family |
| CIB3 | 16133.180 | 19p13.12 | calcium and integrin binding family member 3 |
| CALR3 | 16450.888 | 19p13.11 | calreticulin 3 |
| SIN3B | 16801.218 | 19p13.12 | SIN3 homolog B, transcription regulator (yeast) |
| F2RL3 | 16860.826 | 19p12 | coagulation factor II (thrombin) receptor-like 3 |
| NY-SAR-48 | 17021.573 | 19p13.11 | sarcoma antigen NY-SAR-48 |
| NR2F6 | 17203.695 | 19p13.1 | nuclear receptor subfamily 2, group F, member 6 |
| PLVAP | 17323.264 | 19p13.2 | plasmalemma vesicle associated protein |
| INSL3 | 17788.322 | 19p13.2-p12 | insulin-like 3 (Leydig cell) |
| JAK3 | 17797.961 | 19p13.1 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) |
| SLC5A5 | 17843.782 | 19p13.2-p12 | solute carrier family 5 (sodium iodide symporter), member 5 |
| IL12RB1 | 18042.373 | 19p13.1 | interleukin 12 receptor, beta 1 |
| MAST3 | 18069.603 | 19p13 | microtubule associated serine/threonine kinase 3 |
| IFI30 | 18145.579 | 19p13.1 | interferon, gamma-inducible protein 30 |
| RAB3A | 18168.611 | 19p13.2 | RAB3A, member RAS oncogene family |
| JUND | 18251.571 | 19p13.2 | jun D proto-oncogene |
| LSM4 | 18278.718 | 19p13.11 | LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
| PGPEP1 | 18312.408 | 19p13.11 | pyroglutamyl-peptidase I |
| GDF15 | 18357.968 | 19p13.11 | growth differentiation factor 15 |
| ISYNA1 | 18406.625 | 19p13.11 | myo-inositol 1-phosphate synthase A1 |
| ELL | 18414.474 | 19p13.1 | elongation factor RNA polymerase II |
| FKBP8 | 18503.568 | 19p12 | FK506 binding protein 8, 38kDa |
| CRTC1 | 18655.425 | 19p13 | CREB regulated transcription coactivator 1 |
| COMP | 18754.583 | 19p13.1 | cartilage oligomeric matrix protein |
| UPF1 | 18803.744 | 19p13.2-p13.11 | UPF1 regulator of nonsense transcripts homolog (yeast) |
| GDF1 | 18840.361 | 19p12 | growth differentiation factor 1 |
| COPE | 18871.324 | 19p13.11 | coatomer protein complex, subunit epsilon |
| DDX49 | 18891.494 | 19p12 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 |
| SLC25A42 | 19035.808 | 19p13.11 | solute carrier family 25, member 42 |
| RFXANK | 19164.008 | 19p12 | regulatory factor X-associated ankyrin-containing protein |
| PBX4 | 19533.524 | 19p12 | pre-B-cell leukemia homeobox 4 |
| EDG4 | 19595.477 | 19p12 | lysophosphatidic acid receptor 2 |
| LPAR2 | 19595.477 | 19p12 | lysophosphatidic acid receptor 2 |
| ZNF85 | 20897.934 | 19p12 | zinc finger protein 85 |
| ZNF43 | 21779.594 | 19p13.1-p12 | zinc finger protein 43 |
| UQCRFS1 | 34390.007 | 19q12 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
| CCNE1 | 34995.401 | 19q12 | cyclin E1 |
| PDCD5 | 37763.944 | 19q12-q13.1 | programmed cell death 5 |
| C19orf40 | 38155.018 | 19q13.11 | chromosome 19 open reading frame 40 |
| CEBPA | 38482.776 | 19q13.1 | CCAAT/enhancer binding protein (C/EBP), alpha |
| CEBPG | 38556.449 | 19q13.11 | CCAAT/enhancer binding protein (C/EBP), gamma |
| PEPD | 38569.703 | 19q13.11 | peptidase D |
| GPI | 39547.909 | 19q13.1 | glucose phosphate isomerase |
| WTIP | 39664.720 | 19q13.11 | Wilms tumor 1 interacting protein |
| HPN | 40223.250 | 19q11-q13.2 | hepsin (transmembrane protease, serine 1) |
| FXYD3 | 40298.639 | 19q13.11-q13.12 | FXYD domain containing ion transport regulator 3 |
| FXYD5 | 40337.467 | 19q13.12 | FXYD domain containing ion transport regulator 5 |
| LSR | 40431.399 | 19q13.12 | lipolysis stimulated lipoprotein receptor |
| USF2 | 40451.736 | 19q13 | upstream transcription factor 2, c-fos interacting |
| CD22 | 40511.919 | 19q13.1 | CD22 molecule |
| FFAR1 | 40534.295 | 19q13.1 | free fatty acid receptor 1 |
| GAPDHS | 40716.154 | 19q13.1 | glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
| ETV2 | 40824.487 | 19q13.11 | ets variant gene 2 |
| COX6B1 | 40830.995 | 19q13.1 | cytochrome c oxidase subunit Vib polypeptide 1 (ubiquitous) |
| UPK1A | 40849.555 | 19q13.13 | uroplakin 1A |
| MLL4 | 40900.761 | 19q13.1 | myeloid/lymphoid or mixed-lineage leukemia 4 |
| PSENEN | 40928.334 | 19q13.12 | presenilin enhancer 2 homolog (C. elegans) |
| HSPB6 | 40937.310 | 19q13.13 | heat shock protein, alpha-crystallin-related, B6 |
| HCST | 41085.222 | 19q13.1 | hematopoietic cell signal transducer |
| ALKBH6 | 41191.863 | 19q13.12 | alkB, alkylation repair homolog 6 (E. coli) |
| COX7A1 | 41333.664 | 19q13.1 | cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
| ZNF146 | 41397.344 | 19q13.1 | zinc finger protein 146 |
| HKR1 | 42517.420 | 19q13.12 | GLI-Kruppel family member HKR1 |
| PPP1R14A | 43433.719 | 19q13.1 | protein phosphatase 1, regulatory (inhibitor) subunit 14A |
| SPINT2 | 43447.042 | 19q13.1 | serine peptidase inhibitor, Kunitz type, 2 |
| C19orf33 | 43486.644 | 19q13.2 | chromosome 19 open reading frame 33 |
| RASGRP4 | 43591.538 | 19q13.1 | RAS guanyl releasing protein 4 |
| RYR1 | 43616.180 | 19q13.1 | ryanodine receptor 1 (skeletal) |
| MAP4K1 | 43770.121 | 19q13.1-q13.4 | mitogen-activated protein kinase kinase kinase kinase 1 |
| ACTN4 | 43830.167 | 19q13 | actinin, alpha 4 |
| LGALS7 | 43953.448 | 19q13.13 | lectin, galactoside-binding, soluble, 7 (galectin 7) |
| GAL7 | 43971.682 | 19q13.2 | galectin-7 |
| LGALS4 | 43984.155 | 19q13.2 | lectin, galactoside-binding, soluble, 4 (galectin 4) |
| SIRT2 | 44061.040 | 19q13 | sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae) |
| NFKBIB | 44082.455 | 19q13.1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
| PAK4 | 44308.260 | 19q13.2 | p21 protein (Cdc42/Rac)-activated kinase 4 |
| IL28A | 44450.997 | 19q13.13 | interleukin 28A (interferon, lambda 2) |
| IL29 | 44478.805 | 19q13.13 | interleukin 29 (interferon, lambda 1) |
| PAF1 | 44568.112 | 19q13.1 | Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae) |
| MED29 | 44573.803 | 19q13.2 | mediator complex subunit 29 |
| ZFP36 | 44589.327 | 19q13.1 | zinc finger protein 36, C3H type, homolog (mouse) |
| PLEKHG2 | 44595.590 | 19q13.2 | pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
| SUPT5H | 44628.128 | 19q13 | suppressor of Ty 5 homolog (S. cerevisiae) |
| DLL3 | 44681.427 | 19q13.2 | delta-like 3 (Drosophila) |
| EID2 | 44721.289 | 19q13.2 | EP300 interacting inhibitor of differentiation 2 |
| LGALS13 | 44785.009 | 19q13.1 | lectin, galactoside-binding, soluble, 13 (galectin 13) |
| CLC | 44913.736 | 19q13.1 | Charcot-Leyden crystal protein |
| DYRK1B | 45007.831 | 19q12-q13.1 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| FBL | 45016.938 | 19q13.1 | fibrillarin |
| MAP3K10 | 45389.491 | 19q13.2 | mitogen-activated protein kinase kinase kinase 10 |
| AKT2 | 45428.064 | 19q13.1-q13.2 | v-akt murine thymoma viral oncogene homolog 2 |
| HIPK4 | 45577.019 | 19q13.2 | homeodomain interacting protein kinase 4 |
| SERTAD1 | 45620.249 | 19q13.1-q13.2 | SERTA domain containing 1 |
| SERTAD3 | 45638.591 | 19q13.2 | SERTA domain containing 3 |
| LTBP4 | 45799.117 | 19q13.1-q13.2 | latent transforming growth factor beta binding protein 4 |
| NUMBL | 45863.654 | 19q13.13-q13.2 | numb homolog (Drosophila)-like |
| ADCK4 | 45889.274 | 19q13.2 | aarF domain containing kinase 4 |
| MIA | 45973.140 | 19q13.32-q13.33 | melanoma inhibitory activity |
| RAB4B | 45976.011 | 19q13.2 | RAB4B, member RAS oncogene family |
| EGLN2 | 45996.888 | 19q13 | egl nine homolog 2 (C. elegans) |
| CYP2A6 | 46041.284 | 19q13.2 | cytochrome P450, family 2, subfamily A, polypeptide 6 |
| CYP2B6 | 46189.044 | 19q13.2 | cytochrome P450, family 2, subfamily B, polypeptide 6 |
| CYP2A13 | 46286.208 | 19q13.2 | cytochrome P450, family 2, subfamily A, polypeptide 13 |
| CYP2F1 | 46312.193 | 19q13.2 | cytochrome P450, family 2, subfamily F, polypeptide 1 |
| CYP2S1 | 46390.955 | 19q13.1 | cytochrome P450, family 2, subfamily S, polypeptide 1 |
| AXL | 46416.948 | 19q13.1 | AXL receptor tyrosine kinase |
| TGFB1 | 46528.491 | 19q13.1 | transforming growth factor, beta 1 |
| B3GNT8 | 46623.105 | 19q13 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
| CEACAM4 | 46817.184 | 19q13.2 | carcinoembryonic antigen-related cell adhesion molecule 4 |
| CEACAM7 | 46869.075 | 19q13.2 | carcinoembryonic antigen-related cell adhesion molecule 7 |
| CEACAM5 | 46904.370 | 19q13.1-q13.2 | carcinoembryonic antigen-related cell adhesion molecule 5 |
| CEACAM6 | 46951.341 | 19q13.2 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
| CEACAM3 | 46992.374 | 19q13.2 | carcinoembryonic antigen-related cell adhesion molecule 3 |
| RPS19 | 47055.828 | 19q13.2 | ribosomal protein S19 |
| CD79A | 47073.030 | 19q13.2 | CD79a molecule, immunoglobulin-associated alpha |
| ARHGEF1 | 47079.107 | 19q13.13 | Rho guanine nucleotide exchange factor (GEF) 1 |
| RABAC1 | 47152.678 | 19q13.2 | Rab acceptor 1 (prenylated) |
| POU2F2 | 47284.513 | 19q13.2 | POU class 2 homeobox 2 |
| GSK3A | 47426.178 | 19q13 | glycogen synthase kinase 3 alpha |
| ERF | 47443.557 | 19q13 | Ets2 repressor factor |
| CIC | 47480.657 | 19q13.2 | capicua homolog (Drosophila) |
| CXCL17 | 47624.536 | 19q13.2 | chemokine (C-X-C motif) ligand 17 |
| CEACAM1 | 47703.299 | 19q13.2 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
| CEACAM8 | 47776.235 | 19q13.2 | carcinoembryonic antigen-related cell adhesion molecule 8 |
| PSG2 | 48260.202 | 19q13.1-q13.2 | pregnancy specific beta-1-glycoprotein 2 |
| PSG9 | 48449.275 | 19q13.2 | pregnancy specific beta-1-glycoprotein 9 |
| LYPD3 | 48656.786 | 19q13.31 | LY6/PLAUR domain containing 3 |
| XRCC1 | 48739.304 | 19q13.2 | X-ray repair complementing defective repair in Chinese hamster cells 1 |
| CADM4 | 48818.362 | 19q13.32 | cell adhesion molecule 4 |
| PLAUR | 48844.572 | 19q13 | plasminogen activator, urokinase receptor |
| KCNN4 | 48962.527 | 19q13.2 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
| ZNF224 | 49290.337 | 19q13.2 | zinc finger protein 224 |
| PVR | 49839.066 | 19q13.2 | poliovirus receptor |
| BCL3 | 49943.818 | 19q13.1-q13.2 | B-cell CLL/lymphoma 3 |
| CBLC | 49972.988 | 19q13.2 | Cas-Br-M (murine) ecotropic retroviral transforming sequence c |
| BCAM | 50004.178 | 19q12-q13 | basal cell adhesion molecule (Lutheran blood group) |
| PVRL2 | 50041.233 | 19q13.2-q13.4 | poliovirus receptor-related 2 (herpesvirus entry mediator B) |
| APOC1 | 50109.761 | 19q13.2 | apolipoprotein C-I |
| CLPTM1 | 50150.478 | 19q13.3 | cleft lip and palate associated transmembrane protein 1 |
| RELB | 50196.552 | 19q13.32 | v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (avian) |
| EXOC3L2 | 50407.719 | 19q13.32 | exocyst complex component 3-like 2 |
| MARK4 | 50446.682 | 19q13.3 | MAP/microtubule affinity-regulating kinase 4 |
| MAG | 50534.289 | 19q13.1 | malignancy-associated gene |
| ERCC2 | 50546.686 | 19q13.3 | excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) |
| PPP1R13L | 50574.739 | 19q13.32 | protein phosphatase 1, regulatory (inhibitor) subunit 13 like |
| CD3EAP | 50601.307 | 19q13.3 | CD3e molecule, epsilon associated protein |
| ERCC1 | 50608.533 | 19q13.32 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
| FOSB | 50663.093 | 19q13.32 | FBJ murine osteosarcoma viral oncogene homolog B |
| VASP | 50702.528 | 19q13.2-q13.3 | vasodilator-stimulated phosphoprotein |
| GPR4 | 50784.865 | 19q13.3 | G protein-coupled receptor 4 |
| FBXO46 | 50905.727 | 19q13.3 | F-box protein 46 |
| DMPK | 50964.816 | 19q13.3 | dystrophia myotonica-protein kinase |
| FOXA3 | 51059.358 | 19q13.2-q13.4 | forkhead box A3 |
| NOVA2 | 51134.631 | 19q13.3 | neuro-oncological ventral antigen 2 |
| HIF3A | 51498.716 | 19q13 | hypoxia inducible factor 3, alpha subunit |
| PPP5C | 51542.134 | 19q13.3 | protein phosphatase 5, catalytic subunit |
| PTGIR | 51815.566 | 19q13.3 | prostaglandin I2 (prostacyclin) receptor (IP) |
| GNG8 | 51829.174 | 19q13.32 | guanine nucleotide binding protein (G protein), gamma 8 |
| DACT3 | 51842.710 | 19q13.32 | dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis) |
| PRKD2 | 51869.413 | 19q13.2 | protein kinase D2 |
| SLC1A5 | 51969.982 | 19q13.3 | solute carrier family 1 (neutral amino acid transporter), member 5 |
| DHX34 | 52544.386 | 19q13.3 | DEAH (Asp-Glu-Ala-His) box polypeptide 34 |
| NAPA | 52682.703 | 19q13.33 | N-ethylmaleimide-sensitive factor attachment protein, alpha |
| GLTSCR1 | 52803.265 | 19q13.3 | glioma tumor suppressor candidate region gene 1 |
| GLTSCR2 | 52940.620 | 19q13.3 | glioma tumor suppressor candidate region gene 2 |
| SULT2A1 | 53065.683 | 19q13.3 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
| PLA2G4C | 53242.917 | 19q13.3 | phospholipase A2, group IVC (cytosolic, calcium-independent) |
| LIG1 | 53310.515 | 19 | ligase I, DNA, ATP-dependent |
| CARD8 | 53403.325 | 19q13.3 | caspase recruitment domain family, member 8 |
| EMP3 | 53520.441 | 19q13.3 | epithelial membrane protein 3 |
| PSCD2 | 53664.424 | 19q13.32 | pleckstrin homology, Sec7 and coiled-coil domains 2 (cytohesin-2) |
| FUT2 | 53891.040 | 19q13.3 |